Search hospitals > Florida > Fort Lauderdale
UM Sylvester Comprehensive Cancer Center at Plantation
Claim this profileFort Lauderdale, Florida 33324
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Melanoma
93 reported clinical trials
40 medical researchers
Summary
UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Lung Cancer, Melanoma and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 204 conditions. There are 40 research doctors associated with this hospital, such as Jose Lutzky, MD, Marilyn Huang, Macarena I. De La Fuente, and Chukwuemeka (Emeka) V. Ikpeazu.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Recurrence
Global LeaderStage IV
Stage III
IDH positive
Top PIs
Jose Lutzky, MDUniversity of Miami3 years of reported clinical research
Expert in Melanoma
Studies Cancer
19 reported clinical trials
33 drugs studied
Marilyn HuangUniversity of Miami2 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
13 reported clinical trials
39 drugs studied
Macarena I. De La FuenteUniversity of Miami Miller School of Medicine-Sylvester Cancer Center1 year of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
12 reported clinical trials
27 drugs studied
Chukwuemeka (Emeka) V. IkpeazuUniversity of Miami Miller School of Medicine-Sylvester Cancer Center1 year of reported clinical research
Studies Cancer
Studies Recurrence
11 reported clinical trials
32 drugs studied
Clinical Trials running at UM Sylvester Comprehensive Cancer Center at Plantation
Breast Cancer
Melanoma
Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Cutaneous Melanoma
Lung Cancer
Skin Cancer
Gallbladder Cancer
Recurrence
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This study is evaluating whether a combination of two drugs may help prevent breast cancer from coming back.
Recruiting1 award Phase 313 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at UM Sylvester Comprehensive Cancer Center at Plantation?
UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Lung Cancer, Melanoma and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 204 conditions. There are 40 research doctors associated with this hospital, such as Jose Lutzky, MD, Marilyn Huang, Macarena I. De La Fuente, and Chukwuemeka (Emeka) V. Ikpeazu.